WebNov 10, 2024 · Dermata Therapeutics Provides Corporate Update and Reports Full Year 2024 Financial Results . Dec 05, 2024 8:30am EST. Dermata Announces Topline Results from DMT310 Phase 2 Clinical … WebGet the detailed quarterly/annual income statement for Dermata Therapeutics, Inc. (DRMA). Find out the revenue, expenses and profit or loss over the last fiscal year.
Dermata Therapeutics Inc (DRMA) Quote - Investors Hub
WebDermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for … WebApr 11, 2024 · Dermata Therapeutics Inc has a Value Score of 82, which is considered to be undervalued. Dermata Therapeutics Inc’s price-to-book ratio is higher than its peers. This could make Dermata Therapeutics Inc less attractive for value investors when compared to the industry median at 1.41. graphic web editor
Press Releases :: Dermata Therapeutics, Inc. (DRMA)
WebInvista em Dermata Therapeutics, NASDAQ: DRMA Ação - Veja o preçário DRMA em tempo real. Comissões grátis online em investimentos em Dermata Therapeutics: … WebMarch 13, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Dermata … WebCompany Info Dermata Therapeutics Inc. 3525 Del Mar Heights Road Suite 322 San Diego California 92130 United States Email Website Map Employees 8 Sector Pharmaceuticals Sales or Revenue -... graphic web development